Alignment Healthcare, Inc
Case Overview
| Status: | Status: Investigating |
| Company Name: | Company Name: Alignment Healthcare, Inc |
| Ticker: | Ticker: ALHC |
| Related Attorneys: | Lead Attorneys: Thomas W. Elrod |
| Related Practices: | Related Practices: Securities |
The law firm of Kirby McInerney LLP is investigating potential claims against Alignment Healthcare, Inc. (“Alignment Healthcare” or the “Company”) (NASDAQ:ALHC). The investigation concerns whether the Company and/or members of its senior management may have violated federal securities laws or engaged in other unlawful business practices.
On July 8, 2026, it was reported that a former executive at Alignment Healthcare filed a whistleblower lawsuit alleging that the Company manipulated its finances to boost its stock price and executive compensation.
The whistleblower, who was employed by Alignment from 2019 to 2025 and most recently served as the Company’s chief transformation officer, alleges that Alignment Healthcare misclassified operating expenses as capital expenditures. These actions purportedly boosted the Company’s adjusted EBITDA for 2024 and 2025, thereby artificially inflating key performance metrics tied to both the Company’s stock price and executive compensation. On this news, the price of Alignment Healthcare shares declined by $4.02 per share, or approximately 17%, from $24.05 per share on July 7, 2026 to close at $20.03 on July 8, 2026.
On July 8, 2026, it was reported that a former executive at Alignment Healthcare filed a whistleblower lawsuit alleging that the Company manipulated its finances to boost its stock price and executive compensation.
The whistleblower, who was employed by Alignment from 2019 to 2025 and most recently served as the Company’s chief transformation officer, alleges that Alignment Healthcare misclassified operating expenses as capital expenditures. These actions purportedly boosted the Company’s adjusted EBITDA for 2024 and 2025, thereby artificially inflating key performance metrics tied to both the Company’s stock price and executive compensation. On this news, the price of Alignment Healthcare shares declined by $4.02 per share, or approximately 17%, from $24.05 per share on July 7, 2026 to close at $20.03 on July 8, 2026.